Risk factors for breakthrough COVID-19 in 15,804 UK adults after primary and booster doses of SARS-CoV-2 vaccines

G. Vivaldi (London, United Kingdom), D. Jolliffe (London, United Kingdom), H. Holt (London, United Kingdom), M. Talaei (London, United Kingdom), F. Tydeman (London, United Kingdom), S. Shaheen (London, United Kingdom), A. Martineau (London, United Kingdom)

Source: International Congress 2022 – Determinants, diagnosis and management of lung diseases in adults

Session: Determinants, diagnosis and management of lung diseases in adults
Session type: Thematic Poster
Number: 3220

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Vivaldi (London, United Kingdom), D. Jolliffe (London, United Kingdom), H. Holt (London, United Kingdom), M. Talaei (London, United Kingdom), F. Tydeman (London, United Kingdom), S. Shaheen (London, United Kingdom), A. Martineau (London, United Kingdom). Risk factors for breakthrough COVID-19 in 15,804 UK adults after primary and booster doses of SARS-CoV-2 vaccines. 3220

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.